Wyeth

Parent Organization: Pfizer Inc

Wyeth, formerly one of the companies owned by American Home Products Corporation (AHP), was a pharmaceutical company. The company was based in Madison, New Jersey, USA. They were known for manufacturing the over-the-counter (OTC) drugs Robitussin and the analgesic Advil (ibuprofen), as well as the prescription drugs Premarin and Effexor, which both boast over US$3 billion in sales annually.

Source: Wikipedia

Campaign Finance

$14,960 Given
Information

Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:

  • contributions under $200 are not reported, and so are not included in totals.
  • only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
  • contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
  • corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
  • organization totals include known subsidiaries of the organization.

For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.

covers through 2011

  • Top Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.

  • Republicans vs. Democrats

    in dollars

  • State vs. Federal

    in dollars

  • Top PAC Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.
View all campaign finance data for Wyeth Sources: OpenSecrets.org FollowTheMoney.org

Regulations

27 Mentions; 2 Submissions
Information

All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.

Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.

Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.

Regulations and public comments can be downloaded in bulk here.

updated from Regulations.gov on September 27, 2011

The tables show occurrences of "Wyeth" in public comments on proposed federal regulations.

  • Documents Submitted by the Organization
    • Submissions
    • Agency
    • Docket
    • Date
    • Toggle 2 FDA Patent Term Extension Application for Prevnar 13®, U.S. Patent No.5,614,382 2011
    • Toggle 1 FDA Bristol-Myers Squibb Co. et al.; Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications - CLOSED 2011
  • Mentions in Document Text
    • Mentions
    • Agency
    • Docket
    • Date
    • Toggle 2 FWS Revise the List of Endangered and Threatened Wildlife for the Gray Wolf ( Canis lupus ) in the Eastern United States 2011
    • Toggle 2 FDA Patent Term Extension Application for Prevnar 13®, U.S. Patent No.5,614,382 2011
    • Toggle 2 FDA Patent Term Extension Application for NUEDEXTA™, U.S. Patent No. 5,206,248 2011
    • Toggle 2 FDA Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications; Chorionic Gonadotropin, Cuprimyxin, Diethylcarbamazine; Levamisole, Nitrofurazone, Phenylbutazone; Pyrantel; Tylosin; Tylosin and Sulfamethazine. 2011
    • Toggle 2 FDA NADA/ANADA Notices 2011
    • Toggle 2 FDA Bristol-Myers Squibb Co. et al.; Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications - CLOSED 2011
    • Toggle 2 FDA Patent Term Extension Application for NUEDEXTA™, U.S. Patent No. RE38,115 2011
    • Toggle 2 APHIS Oral Rabies Vaccine Trial; Availability of a Risk Assessment and an Environmental Assessment 2011
    • Toggle 1 FDA Refrain From Approving any Abbreviated New Drug Application (ANDA) for Which Taclonex® Ointment (Calcipotriene 0.005% and Betamethasone Dipropionate 0.064%) and Taclonex Scalp® Topical Suspension (Calcipotriene 0.005% and Betamthasone Dipropionate 0.064%) is the Reference List Drug (RLD) Until the Following Conditions are Satisfied 2011
    • Toggle 1 EPA Oregon Authorization of State Hazardous Waste Management Program, Base Authorization Application, Authorization Effective January 31, 1986 2011

Federal Spending

2 contracts
Information

Federal grants, contracts and loans are reported by federal agencies using the FPDS and FAADS systems. The data is made available to the public at USASpending.gov. Please note that the completeness and quality of the data varies greatly by agency.

Only grants, contracts and loans with amounts over $1 million are shown.

Because company names are not reported in a standardized manner, we cannot reliably determine the company receiving the contract or award. The results shown here are based on a search for the company name. Individual records may be missed or erroneously included because of name variations. For more information, please see our federal spending methodology page.

covers through USASpending.gov's March 1, 2012 release

Note: Company names in federal spending data are not standardized. The table below is included only as a sample of what is available in the data and has not been reviewed for accuracy or completeness. To investigate the data further, use the links at the bottom of the table.

Type Recipient Name Year Agency Description Amount
contract
 Wyeth 2011 Centers For Disease Control TAS::75 0512::TAS 00HCVGBC-2010-82344 - PFIZER/WYETH PEDIATRIC VACCINE CONTRACT $308,849,720
contract
 Wyeth 2011 Centers For Disease Control 00HCVGBC-2010-82344 - PFIZER/WYETH PEDIATRIC VACCINE CONTRACT $213,282,692
View all grant & loan data for Wyeth View all contract data for Wyeth Sources: USASpending.gov

Contractor Misconduct

1 Instances
Information

This information is collected by the Project On Government Oversight from press releases, court documents, news reports and other public records. It is not meant to be an exhaustive account of all instances of federal contractor misconduct.

More information on each instance, including primary source documents, is available on POGO's site by clicking on the instance description. More information on POGO's methodology is available here.

covers through POGO's March 3, 2012 release
Misconduct Type Hired By Incident Year Disposition Penalty
Health None Daniel v. Wyeth (Prempro) 2011 Judgment Against Defendant $1,681,650
View all contractor misconduct data for Wyeth Sources: Federal Contractor Misconduct Database from POGO

Advisory Committees

3 people on 3 committees
Information

Data is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.

The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.

covers through 2011

Table shows employees of "Wyeth" that sat on federal advisory committees.

  • Agency
  • Representation
  • Toggle Department of Health and Human Services 3 people on 3 committees
View all advisory committee data for Wyeth